Re-Pharm is an early-stage drug discovery and development company based on the principles of compound re-profiling. Our goal is to identify compounds currently on the market, or previously failed to make it to market for commercial reasons, and re-purpose them to address diseases in areas of unmet medical need.
State of Ownership
Business Development Executive, Nature Publishing Group, Springer Nature
Sales Account Executive, Springer Nature
Former Head of Communities, Springer Nature
Managing Director, Thoroughly Good Consulting
Global Manager, Business Development, Nature Publishing Group
CEO & Co-Founder, Zapnito